HomeNewsPress ReleaseTom Watson appointed Chief Executive Officer

Tom Watson appointed Chief Executive Officer.

  • Published 02/08/2022
  • Categories Press Release
  • Download Download

2 August 2022. Bionical Emas, a global Contract Research Organisation (CRO) providing services to the pharmaceutical and biotech sectors, has appointed Tom Watson as its Chief Executive Officer (CEO). Jonathan Waring-Hughes has left the business.

Tom joined Bionical Emas four years ago. For the last year he has been on Bionical Emas’ board as Chief Operating Officer (COO). Before that, he led the Group’s rapidly growing Early Access Programs (EAP) business.

We are delighted to appoint Tom as Chief Executive Officer. He has operated across the international clinical research and services sector for many years and brings considerable experience and expertise.

The Board looks forward to supporting the business continue to go from strength to strength over the coming years.

Andrew Borkowski, Chairman at Bionical Emas

Contact details

Bionical Emas
Katie Clayton, Head of Marketing
+44 (0) 1462 416435

Meare Consulting
Adrian Duffield
+44 (0) 7990 85 85 48

Note to Editors

Bionical Emas is a Contract Research Organisation (CRO) which combines Clinical Development, Early Access Program (EAP) and Clinical Trial Supply (CTS) services to deliver a unique, seamless approach to pioneering the way life-changing medicines are developed and accessed for patients around the world.

The Group deliver full clinical development services to global pharma and biotech companies. It’s integrated suite of services enables Bionical Emas to maximize access, collect data and generate evidence at every point along the drug development pathway.

Bionical Emas runs global programs, employs 250 people, and has offices in US, Europe, and Australia. It serves 10 of the top 25 pharma companies.

How can we support you?

Our dedicated teams of experts are on hand to help should you require any additional resource or further information about our services.

COVID-19 Guidance & Measures

A statement from the Bionical Emas Group on guidance & measures regarding COVID-19 - read here

In relation to staff and visitor safety, we have full risk assessments in place for all of our workplaces. These risk assessments are revisited and updated regularly, to reflect changing risks, knowledge and circumstances, and to reflect evolving Government guidance. We have not placed the risk assessments here on the website as they would become out of date too quickly. However, you are welcome to email info@bionical-emas.com to request access to our most up to date risk assessments applicable to your needs. Please note that all our staff are notified of all applicable risk assessments and updates, along with ‘quick guides’ automatically via our e-learning system.